Table 3. List of the 29 known genes located in the 5 Mb minimal region of amplification at 17q23 and their minimum, maximum and median expression levels in 26 primary breast tumours.
Gene | Description | Min | Max | Median |
---|---|---|---|---|
SEPT4 | Peanut-like protein 2 | ND | ND | ND |
TEX14 | Testis expressed sequence 14 | ND | ND | ND |
RAD51C | DNA repair protein RAD51 homolog | 0.0 | 1.9 | 0.3 |
PPM1E | Protein phosphatase 1E | 0.0 | 1.7 | 0.0 |
TRIM37 | Tripartite motif-containing 37 protein | 0.0 | 1.1 | 0.2 |
FAM33A | Family with sequence similarity 33, member A | 0.0 | 3.3 | 0.3 |
YPEL2 | Yippee-like 2 protein | 0.1 | 1.0 | 0.3 |
DHX40 | DEAH (Asp-Glu-Ala-His) box polypeptide 40 | 0.0 | 4.5 | 0.2 |
CLTC | Clathrin heavy chain 1 | 0.0 | 3.7 | 0.4 |
PTRH2 | Peptidyl-tRNA hydrolase 2 | 0.1 | 14.8 | 1.4 |
TMEM49 | Transmembrane protein 49 | 0.0 | 1.2 | 0.2 |
TUBD1 | Tubulin δ chain | 0.0 | 2.4 | 0.3 |
RPS6KB1 | Ribosomal protein S6 kinase | 0.0 | 1.0 | 0.2 |
ABC1 | Amplified in breast cancer | 0.0 | 1.7 | 0.3 |
CA4 | Carbonic anhydrase IV precursor | ND | ND | ND |
USP32 | Ubiquitin C-terminal hydrolase 32 | 0.0 | 1.5 | 0.3 |
APPBP2 | Amyloid β precursor protein binding protein 2 | 0.0 | 1.6 | 0.1 |
PPM1D | Protein phosphatase 2C δ isoform, magnesium-dependent | 0.0 | 2.8 | 0.2 |
BCAS3 | Breast carcinoma amplified sequence 3 | 0.1 | 2.7 | 0.3 |
TBX2 | T-box transcription factor TBX2 | 0.0 | 0.7 | 0.1 |
TBX4 | T-box transcription factor TBX4 | 0.0 | 9.0 | 0.3 |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | 0.0 | 2.1 | 0.2 |
THRAP1 | Thyroid hormone receptor-associated protein | 0.0 | 1.1 | 0.2 |
TLK2 | Serine/threonine-protein kinase tousled-like 2 | 0.1 | 1.6 | 0.3 |
MRC2 | Mannose receptor, C type 2 | ND | ND | ND |
CYB561 | Cytochrome b561 | 0.3 | 9.2 | 1.3 |
ACE | Angiotensin-converting enzyme, somatic isoform precursor | 4.0 | 233.0 | 32.1 |
KCNH6 | Potassium voltage-gated channel, subfamily H, member 6 | ND | ND | ND |
WRD68 | WD-repeat protein 68 | 0.1 | 1.8 | 0.8 |
ND=not determined (low or now expression in breast cancer cell lines MCF7 and BT-474 with high-level amplification).